Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-24 @ 11:07 PM
NCT ID:
NCT00403169
Brief Title:
Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer
Official Title:
Phase II Study of CC-5013 in Patients With Advanced Renal Cell Carcinoma (RCC)
Study:
NCT00403169
Protocol Section:
NCT00403169